Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy.
Greene SJ, Epstein SE, Kim RJ, Quyyumi AA, Cole RT, Anderson AS, Wilcox JE, Skopicki HA, Sikora S, Verkh L, Tankovich NI, Gheorghiade M, Butler J.
Greene SJ, et al. Among authors: anderson as.
J Cardiovasc Med (Hagerstown). 2017 Apr;18(4):283-290. doi: 10.2459/JCM.0000000000000303.
J Cardiovasc Med (Hagerstown). 2017.
PMID: 26479144
Clinical Trial.